Immune Tolerance Network Revenue and Competitors
Estimated Revenue & Valuation
- Immune Tolerance Network's estimated annual revenue is currently $3.4M per year.
- Immune Tolerance Network's estimated revenue per employee is $81,600
Employee Data
- Immune Tolerance Network has 42 Employees.
- Immune Tolerance Network grew their employee count by -7% last year.
Immune Tolerance Network's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer, Clinical Trials Group | Reveal Email/Phone |
2 | Executive Director, Strategic Review, Planning, and Communications | Reveal Email/Phone |
3 | Director, Bioinformatics | Reveal Email/Phone |
4 | Director, Data Collaboration | Reveal Email/Phone |
5 | Associate Director Clinical Operations | Reveal Email/Phone |
6 | Director Biomarker & Discovery Research | Reveal Email/Phone |
7 | Associate Director, Clinical Operations | Reveal Email/Phone |
8 | Director, Accounting | Reveal Email/Phone |
9 | Director Biomarker Discovery Research for Autoimmunity | Reveal Email/Phone |
10 | Director, Clinical Trial Physician | Reveal Email/Phone |
Immune Tolerance Network Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13M | 127 | 43% | N/A | N/A |
#2 | $11.2M | 110 | 62% | N/A | N/A |
#3 | $27.3M | 243 | 10% | N/A | N/A |
#4 | $26M | 237 | 25% | $11M | N/A |
#5 | $3.3M | 41 | -11% | N/A | N/A |
#6 | $11.6M | 114 | 24% | N/A | N/A |
#7 | $1.6M | 22 | 5% | N/A | N/A |
#8 | $5.9M | 64 | 10% | N/A | N/A |
#9 | $27.8M | 248 | 28% | N/A | N/A |
#10 | $3.7M | 45 | -56% | N/A | N/A |
What Is Immune Tolerance Network?
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies in asthma and allergy, autoimmune diseases, type 1 diabetes and solid organ transplantation. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops, funds and conducts clinical trials in conjunction with mechanistic, laboratory based studies.
keywords:N/A
N/A
Total Funding
42
Number of Employees
$3.4M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.5M | 42 | -5% | N/A |
#2 | $8.4M | 42 | 0% | N/A |
#3 | $10.9M | 42 | 45% | N/A |
#4 | $6.9M | 42 | 17% | N/A |
#5 | $4.7M | 42 | 2% | N/A |